|
|
Article: HearAtLast Holdings, Inc. & Opexa Therapeutics, Inc.
- Article from:
- M2 Presswire
- Article date:
- November 5, 2009
CopyrightCOPYRIGHT 2009 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-5 November 2009-Markettelegraph.com: HearAtLast Holdings, Inc. & Opexa Therapeutics, Inc.(C)1994-2009 M2 COMMUNICATIONS
RDATE:04112009
Boston, MA, -- HearAtLast Holdings, Inc. (PINKSHEETS: HRAL); Opexa Therapeutics, Inc. (NASDAQ: OPXA)
MarketTelegraph.com is part of Stock Profiler.US, LLC's News Division. Stock Profiler welcomes investors to sign up at www.stockprofiler.us. to subscribe to our FREE newsletter. Please follow our thread on www.twitter.com at StockProfilerUS
Stock Profiler is pleased to introduce HearAtLast Holdings, Inc. (PINKSHEETS: HRAL) to the investment community. Please visit us at www.stockprofiler.us ...
Related newspaper, magazine, and journal articles:
|
|
Article: Opexa Therapeutics Presents Tovaxin Phase I/II Data ...
Business Wire;
April 15, 2008 ;
700+ words
...THE WOODLANDS, Texas -- Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved ... patients treated in earlier clinical studies. About Opexa Therapeutics Opexa Therapeutics develops and commercializes cell therapies to treat ...
|
|